# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-24-048014
Filing Date
2024-11-27
Accepted
2024-11-27 16:36:12
Documents
3
Period of Report
2024-11-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formpre14a.htm | PRE 14A | 277750
2 |  | formpre14a_001.jpg | GRAPHIC | 660436
3 |  | formpre14a_002.jpg | GRAPHIC | 555608
| Complete submission text file | 0001493152-24-048014.txt |  | 1953651

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38286 | Film No.: 241511796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)